LOL. Check this out: During the month of July, 11 different law firms filed class action lawsuits against SRNE. Afterwards, the price rallied 125%. Or maybe it rallied because SRNE announced the start of phase 2 trials on one of their drugs? I think the lawsuits gave this company more exposure than the phase 2 trials alone.
Currently in Phase 1 of COVID antibody...
This stock had 100M volume today-- which is unusual, therefore significant. I did some forensic analysis of their news and it appears that they had a phase 3 survival events failure which means that the meds they were testing did not increase the chances of survival among cancer patients.
Now they start over again (Phase 1) on their other cancer drugs.
Emergent BioSolutions is well known for owning the rights to the pioneering technology behind the Narcan nasal spray. Naloxone has been around for years as an injectable for opioid overdoses which required expertise to administer. Narcan spray eliminated the expertise requirement.
Recently, EBS entered into several large contracts with giant pharma and will...
This is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock.
EVOK has an analyst sell target at $10. I believe that with a float of 24M, this stock has the stock characteristics to hit $10 and maybe even further. And why is it positive when everything else is down???
Mega resistance between $0.80 and $1
$1.25 also very hard to break. However, I'm seeing block trades eating away at the ask. Only 4% of shares belong to institution or insiders-- which means they'll have to keep buying for weeks in order to have a position.
Amazing things happen when almost all of the supply of shares is "off limits" to market participants. I've seen this before in other companies prior to COVID stock meltdown, where insiders continually buy their own stock until more than 90% of it is in their control. After this period of buying, they start releasing PR and the hype cycle begins. Exit when they exit.
For the past 2 months, it looks like they've (insiders) been accumulating this stock. They buy a bunch; wait for price to drop, then buy a bunch. Might as well skim a few dollars while this stock is still (relatively) predictable.
Saw some good insider buys and this stock is also low float (19M supply) which is about half of Kodak (45M supply). It's only going to take one good news story to blow this stock into hyperspace. Trend line is perfect.